Skip Nav Destination
Issues
What do internal medicine residents need to enhance their diabetes care?
Diabetes Care May 1999, Vol.22, 661-666. doi:https://doi.org/10.2337/diacare.22.5.661
Therapy of severe diabetic ketoacidosis. Zero-mortality under very-low-dose insulin application.
Diabetes Care May 1999, Vol.22, 674-677. doi:https://doi.org/10.2337/diacare.22.5.674
Effects of aerobic or resistance exercise and/or diet on glucose tolerance and plasma insulin levels in obese men.
Diabetes Care May 1999, Vol.22, 684-691. doi:https://doi.org/10.2337/diacare.22.5.684
Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis.
Diabetes Care May 1999, Vol.22, 692-695. doi:https://doi.org/10.2337/diacare.22.5.692
Is there a glycemic threshold for mortality risk?
Diabetes Care May 1999, Vol.22, 696-699. doi:https://doi.org/10.2337/diacare.22.5.696
Risk for metabolic control problems in minority youth with diabetes.
A M Delamater; K H Shaw; E B Applegate; I A Pratt; M Eidson; G X Lancelotta; L Gonzalez-Mendoza; S Richton
Diabetes Care May 1999, Vol.22, 700-705. doi:https://doi.org/10.2337/diacare.22.5.700
Correlates of physical activity in a sample of older adults with type 2 diabetes.
Diabetes Care May 1999, Vol.22, 706-712. doi:https://doi.org/10.2337/diacare.22.5.706
Latino beliefs about diabetes.
Diabetes Care May 1999, Vol.22, 722-728. doi:https://doi.org/10.2337/diacare.22.5.722
Impact of maternal nativity on the prevalence of diabetes during pregnancy among U.S. ethnic groups.
Diabetes Care May 1999, Vol.22, 729-735. doi:https://doi.org/10.2337/diacare.22.5.729
Antidiabetic treatment trends in a cohort of elderly people with diabetes. The cardiovascular health study, 1989-1997.
Diabetes Care May 1999, Vol.22, 736-742. doi:https://doi.org/10.2337/diacare.22.5.736
The 10-year incidence of renal insufficiency in people with type 1 diabetes.
Diabetes Care May 1999, Vol.22, 743-751. doi:https://doi.org/10.2337/diacare.22.5.743
Effect of multiple patient reminders in improving diabetic retinopathy screening. A randomized trial.
Diabetes Care May 1999, Vol.22, 752-755. doi:https://doi.org/10.2337/diacare.22.5.752
Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study.
Diabetes Care May 1999, Vol.22, 756-761. doi:https://doi.org/10.2337/diacare.22.5.756
Impact of new diagnostic criteria for diabetes on different populations.
Diabetes Care May 1999, Vol.22, 762-766. doi:https://doi.org/10.2337/diacare.22.5.762
Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study.
Diabetes Care May 1999, Vol.22, 767-772. doi:https://doi.org/10.2337/diacare.22.5.767
Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry.
Diabetes Care May 1999, Vol.22, 773-778. doi:https://doi.org/10.2337/diacare.22.5.773
Black-white differences in risk of developing retinopathy among individuals with type 2 diabetes.
Diabetes Care May 1999, Vol.22, 779-783. doi:https://doi.org/10.2337/diacare.22.5.779
Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.
Diabetes Care May 1999, Vol.22, 784-788. doi:https://doi.org/10.2337/diacare.22.5.784
A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients.
Diabetes Care May 1999, Vol.22, 789-794. doi:https://doi.org/10.2337/diacare.22.5.789
Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime.
M Ciofetta; C Lalli; P Del Sindaco; E Torlone; S Pampanelli; L Mauro; D L Chiara; P Brunetti; G B Bolli
Diabetes Care May 1999, Vol.22, 795-800. doi:https://doi.org/10.2337/diacare.22.5.795
Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.
Diabetes Care May 1999, Vol.22, 801-805. doi:https://doi.org/10.2337/diacare.22.5.801
Protein metabolism in insulin-treated gestational diabetes.
Diabetes Care May 1999, Vol.22, 806-811. doi:https://doi.org/10.2337/diacare.22.5.806
Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients.
Diabetes Care May 1999, Vol.22, 812-817. doi:https://doi.org/10.2337/diacare.22.5.812
Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.
Diabetes Care May 1999, Vol.22, 818-822. doi:https://doi.org/10.2337/diacare.22.5.818
Abnormality in urinary protein excretion in Japanese men with impaired glucose tolerance.
Diabetes Care May 1999, Vol.22, 823-826. doi:https://doi.org/10.2337/diacare.22.5.823
Impact of peripheral neuropathy on bone density in patients with type 1 diabetes.
Diabetes Care May 1999, Vol.22, 827-831. doi:https://doi.org/10.2337/diacare.22.5.827
Behavioral science in diabetes. Contributions and opportunities.
Diabetes Care May 1999, Vol.22, 832-843. doi:https://doi.org/10.2337/diacare.22.5.832
On the need for outcome trials in preventive pharmacology. Lessons from the recent experience with adverse drug reactions.
Diabetes Care May 1999, Vol.22, 844-845. doi:https://doi.org/10.2337/diacare.22.5.844
Retinopathy risk: what is responsible? Hormones, hyperglycemia, or humalog? Response to Kitzmiller et al.
Diabetes Care May 1999, Vol.22, 846-848. doi:https://doi.org/10.2337/diacare.22.5.846
Reliability of blood glucose self-monitoring and its influence on glycemic control in highly motivated type 1 diabetic patients.
Diabetes Care May 1999, Vol.22, 854-856. doi:https://doi.org/10.2337/diacare.22.5.854a
Coronary heart disease in women with diabetes. Positive association with past hysterectomy and possible benefits of hormone replacement therapy.
Diabetes Care May 1999, Vol.22, 856-857. doi:https://doi.org/10.2337/diacare.22.5.856
Increased nitric oxide levels in aqueous humor of diabetic patients with neovascular glaucoma.
Diabetes Care May 1999, Vol.22, 861-862. doi:https://doi.org/10.2337/diacare.22.5.861a
Renal tubular function affects glycosuria-related urinary excretion of 1,5-anhydroglucitol.
T Fujisawa; H Ikegami; T Tsutsui; Y Kawaguchi; H Ueda; M Shintani; K Nojima; Y Kawabata; M Ono; M Nishino; S Noso; K Yamada; N Babaya; T Ogihara
Diabetes Care May 1999, Vol.22, 863-864. doi:https://doi.org/10.2337/diacare.22.5.863
Plasma magnesium concentration and progression of retinopathy.
Diabetes Care May 1999, Vol.22, 864-865. doi:https://doi.org/10.2337/diacare.22.5.864
Premixed formulations of insulin lispro. Activity profiles in type 1 diabetic patients.
Diabetes Care May 1999, Vol.22, 865-866. doi:https://doi.org/10.2337/diacare.22.5.865
Durable reversal of hypoglycemia unawareness in type 1 diabetes.
Diabetes Care May 1999, Vol.22, 866-867. doi:https://doi.org/10.2337/diacare.22.5.866
Insulin response to intravenous glucose correlates with plasma levels of the tumor necrosis factor receptor-1.
Diabetes Care May 1999, Vol.22, 868-870. doi:https://doi.org/10.2337/diacare.22.5.868
Oxidative stress and antioxidant supplementation in type I diabetes.
Diabetes Care May 1999, Vol.22, 870-873. doi:https://doi.org/10.2337/diacare.22.5.870
Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy.
Diabetes Care May 1999, Vol.22, 874-876. doi:https://doi.org/10.2337/diacare.22.5.874
Association between central adiposity and multimetabolic syndrome in a special cohort of women with prior gestational diabetes.
Diabetes Care May 1999, Vol.22, 876-877. doi:https://doi.org/10.2337/diacare.22.5.876
Increased serum levels of pentosidine, but not carboxymethyl lysine, in type 2 diabetes without obvious diabetic nephropathy.
Diabetes Care May 1999, Vol.22, 877-878. doi:https://doi.org/10.2337/diacare.22.5.877
